Centene Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 26 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 56.60.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Centene Corp is 6.31, ranking 57 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 49.94B, representing a year-over-year increase of 7.13%, while its net profit experienced a year-over-year increase of 17.54%.
Key Metrics
The current valuation score of Centene Corp is 6.53, ranking 51 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -4.32, which is -983.71% below the recent high of 38.16 and -2.61% above the recent low of -4.43.
The current earnings forecast score of Centene Corp is 6.45, ranking 57 out of 75 in the Healthcare Providers & Services industry. The average price target is 40.00, with a high of 72.11 and a low of 28.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Centene Corp is 9.71, ranking 3 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 63.37 and the support level at 43.00, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Centene Corp is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 98.34%, representing a quarter-over-quarter decrease of 4.51%. The largest institutional shareholder is David G. Herro, holding a total of 9.05M shares, representing 1.83% of shares outstanding, with 56.85% decrease in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Centene Corp is 6.72, ranking 27 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 1.07. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Centene Corp’s latest ESG disclosure leads the Healthcare Providers & Services industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
